NCT06110923

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

A Randomized, Open-label and Parallel Study to Evaluate the Pharmacokinetics and Safety of CKD-846 in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 31 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A Clinical trial to compare and evaluate evaluate the pharmacokinetics and safety of CKD-846

Detailed description

A randomized, open-label and parallel study to evaluate the pharmacokinetics and safety of CKD-846 in healthy male subjects

Conditions

• Benign Prostate Hypertrophy(BPH)

Interventions

Type	Name	Description
DRUG	CKD-846	once administration of Investigational Product
DRUG	D091	once administration of Investigational Product per day

Timeline

• Start date: 2023-11-13
• Primary completion: 2024-05-10
• Completion: 2025-03-25
• First posted: 2023-11-01
• Last updated: 2026-01-14

Locations

1 site across 1 country: South Korea